NO850913L - Farmasoeytisk sammensetning, inneholdende azapropazon - Google Patents

Farmasoeytisk sammensetning, inneholdende azapropazon

Info

Publication number
NO850913L
NO850913L NO850913A NO850913A NO850913L NO 850913 L NO850913 L NO 850913L NO 850913 A NO850913 A NO 850913A NO 850913 A NO850913 A NO 850913A NO 850913 L NO850913 L NO 850913L
Authority
NO
Norway
Prior art keywords
azapropazone
pharmaceutical composition
composition containing
carboxylate
molar ratio
Prior art date
Application number
NO850913A
Other languages
English (en)
Norwegian (no)
Inventor
Kim Drummond Rainsford
Michael Wellesley Whitehouse
Original Assignee
Kim Drummond Rainsford
Whitehouse Michael W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kim Drummond Rainsford, Whitehouse Michael W filed Critical Kim Drummond Rainsford
Publication of NO850913L publication Critical patent/NO850913L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO850913A 1984-03-08 1985-03-07 Farmasoeytisk sammensetning, inneholdende azapropazon NO850913L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08406055A GB2155329A (en) 1984-03-08 1984-03-08 A pharmaceutical formulation containing azapropazone

Publications (1)

Publication Number Publication Date
NO850913L true NO850913L (no) 1985-09-09

Family

ID=10557766

Family Applications (1)

Application Number Title Priority Date Filing Date
NO850913A NO850913L (no) 1984-03-08 1985-03-07 Farmasoeytisk sammensetning, inneholdende azapropazon

Country Status (15)

Country Link
US (1) US5034379A (da)
EP (1) EP0154523B1 (da)
JP (1) JPS60215635A (da)
AT (1) ATE41603T1 (da)
AU (1) AU572968B2 (da)
CA (1) CA1256803A (da)
DE (1) DE3568943D1 (da)
DK (1) DK106485A (da)
ES (1) ES8800598A1 (da)
GB (1) GB2155329A (da)
NO (1) NO850913L (da)
NZ (1) NZ211294A (da)
PH (1) PH21053A (da)
PT (1) PT80078B (da)
ZA (1) ZA851642B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668676A (en) * 1985-12-06 1987-05-26 E.I. Du Pont De Nemours And Company Azapropazone prevention of post-ischemic tissue damage
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
EP0278997A1 (de) * 1987-02-17 1988-08-24 Siegfried Aktiengesellschaft Azapropazon-Rektalkapseln
US5229374A (en) * 1992-01-28 1993-07-20 Burton Albert F Method for treatment of lower gastrointestinal tract disorders
CA2132427A1 (en) * 1992-03-19 1993-09-30 Albert F. Burton Method and composition for suppresion of side effects of anti-inflammatory drugs
AU4055993A (en) * 1992-05-15 1993-12-13 University Of British Columbia, The N-acetyl glucosamine as gastroprotective agent
GB9321655D0 (en) * 1993-10-20 1993-12-08 Glyzinc Pharma Ltd Pharmaceutical formulation of aspirin and salicylates
FR2836656B1 (fr) * 2002-03-01 2004-05-28 Michelin Soc Tech Dispositif et procede de traitement des phenomenes de perte de pression et de roulage a plat des pneumatiques d'un vehicule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU511852B2 (en) * 1977-11-09 1980-09-11 Australian National University, The Formulating aspirin andthe like
EP0013783B1 (en) * 1979-01-12 1984-04-04 The Australian National University Protection of the gastric mucosal lining from damage by aspirin and related drugs
EP0028660B1 (de) * 1979-11-10 1985-10-23 Siegfried Aktiengesellschaft Xanthinoxydasehemmer und Verwendung von Benztriazinderivaten

Also Published As

Publication number Publication date
NZ211294A (en) 1987-09-30
DK106485A (da) 1985-09-09
GB8406055D0 (en) 1984-04-11
ES541054A0 (es) 1987-11-16
AU572968B2 (en) 1988-05-19
ES8800598A1 (es) 1987-11-16
EP0154523A2 (en) 1985-09-11
PH21053A (en) 1987-07-03
JPS60215635A (ja) 1985-10-29
CA1256803A (en) 1989-07-04
ATE41603T1 (de) 1989-04-15
AU3950685A (en) 1985-09-12
GB2155329A (en) 1985-09-25
PT80078A (en) 1985-04-01
EP0154523B1 (en) 1989-03-22
EP0154523A3 (en) 1986-06-04
DK106485D0 (da) 1985-03-08
PT80078B (en) 1987-02-23
US5034379A (en) 1991-07-23
ZA851642B (en) 1985-10-30
DE3568943D1 (en) 1989-04-27

Similar Documents

Publication Publication Date Title
GB1463966A (en) Depilatory formulation
ATE214910T1 (de) Schweisshemmendes mittel mit dibenzylidensorbitol
ES8706443A1 (es) Un procedimiento para preparar una solucion parenteral de activador de plasminogeno de tejido (t-pa)
ES2072392T3 (es) Composicion blanqueante.
ATE109660T1 (de) Stabile flüssige formulierung von 5- aminosalizylsäure.
FI854167L (fi) Mun- och tandvaordsmedel.
AU572968B2 (en) Compositions of azapropazone
FI883761A7 (fi) Ionisten tensidien vesipitoisia koostumuksia, joilla on kohonnut viskositeetti
SE7714473L (sv) Lagringsbar blandning som vid upplosning i vatten ger en losning med hog antimikrobiell verkan
SE9102604D0 (sv) Farmaceutiska kompositioner innehaallande furanderivat
JPS52143231A (en) Body scanning agent
ES2061829T3 (es) Solucion acuosa, estable frente al almacenamiento, de alquiltrialcoxisilanos.
GB1302679A (da)
TR23253A (tr) Zorunlu olarak sodyum suelfat meydana gelmeden parafin-sulfoksidasyon-reaksiyon karisimlarindan alkali suelfat bakimindan fakir parafin suelfonot'larinin ve suelfuerik asidin izde edilmesine mahsus usul
FR2622205B1 (fr) Utilisation de sels de metaux alcalins et alcalino-terreux pour rendre visqueuses des solutions aqueuses de surfactifs anioniques, et compositions visqueuses ainsi obtenues
SE7613849L (sv) For injicering ferdigstellda losningar
GB1440875A (en) Antimicrobial composition
CA2026575A1 (en) Stable sodium tetraphenylborate solutions
GB1483684A (en) Benzothiazole derivatives
EP0351809A3 (en) Blood anticoagulant
GB1230298A (da)
GB1216131A (en) Stable, aqueous nystatin preparations
SE8900511D0 (sv) Allrengoeringsmedel